Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -48812.58%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-48812.58%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cardiol Therapeutics Inc.
Market Cap
$151.58M
EBITDA Margin
-48812.58%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.66M
EBITDA Margin
-47.00%
TTM Avg
-68.63%
3Y Avg
-61.93%
5Y Avg
-48.63%
Market Cap
$152.06M
EBITDA Margin
-3676.90%
TTM Avg
-2033.97%
3Y Avg
-1569.70%
5Y Avg
-1569.70%
Market Cap
$146.98M
EBITDA Margin
-550.97%
TTM Avg
-275.49%
3Y Avg
-275.49%
5Y Avg
-275.49%
Market Cap
$148.36M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.31M
EBITDA Margin
-0.19%
TTM Avg
-1.66%
3Y Avg
-11.02%
5Y Avg
-42.72%
Market Cap
$155.86M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. (CRDL) | $151.58M | -48812.58% | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $151.66M | -47.00% | -68.63% | -61.93% | -48.63% |
| Anavex Life Sciences Corp. (AVXL)vs › | $149.20M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $152.06M | -3676.90% | -2033.97% | -1569.70% | -1569.70% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.98M | -550.97% | -275.49% | -275.49% | -275.49% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $148.31M | -0.19% | -1.66% | -11.02% | -42.72% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $157.71M | -2.74% | -4.58% | -13.60% | -7.28% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.33M | 4.91% | 4.91% | 4.91% | 4.91% |
Gross Margin
0.0%
EBITDA Margin
-48812.6%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2021-06-30 | -8086.20% |
